Diversion Control Division, US Department of Justice, Drug Enforcement Administration



Telemedicine Listening SessionOn September 12 and 13, 2023, DEA hosted public listening sessions and received comments from 58 healthcare practitioners, experts, advocates, patients, and other members of the public to inform DEA’s regulations on prescribing controlled substances via telemedicine.

The listening sessions were livestreamed with virtual participation available. A transcript of the listening sessions is forthcoming. All comments and presentations will become part of the official record for the purposes of rulemaking.

DEA received more than 180 requests to present at the Telemedicine Listening Sessions scheduled for September 12 and 13, 2023. DEA thanks the applicants and members of the public for their interest in these rules and their willingness to provide comment. Because of time limitations, DEA selected a portion of the applicants to present during the listening sessions, consistent with the criteria set forth in the notice. DEA welcomes all feedback on its proposed rules and will have another comment period this fall for written comments before the telemedicine rules are finalized.

Previously sent out Notice of Proposed Rulemaking on telemedicine:

Notice: Practice of Telemedicine: Listening Sessions (PDF) (August 7, 2023)

Temporary Rule: Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications (PDF) (May 10, 2023)

Proposed Rule: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation (PDF) (March 1, 2023)

View Telemedicine Listening Session DAY 1, September 12, 2023:

DAY 1 Transcript (PDF)

In Person Commenters:

Commenter Name Organization
1 Robert Krayn, Georgia Gaveras Talkiatry
2 Shabana Khan American Psychiatric Association
3 David Hoffman Columbia University
4 Kyle Zebley American Telemedicine Association/ata Action
5 Helen Hughes Johns Hopkins Medicine
6 Brian Clear Bicycle Health Medical Group, P.A.
7 Thomas Milam Iris Telehealth, Inc
8 Melanie Melville, Lindsay Lanagan Legacy Community Health Services
9 Daniel Reck Matclinics
10 Dori Martini Circle Medical
11 Lori Uscher-Pines Rand
12 James Lewis American Society of Consultant Pharmacists
13 Chris Adamec Alliance for Connected Care
14 Edward Kaftarian, M.D. Practitioner
15 Joseph Rotella, M.D. American Academy of Hospice and Palliative Medicine
Virtual Commenters:

Commenter Name Organization
1 Elizabeth Linderbaum National Association of Community Health Centers
2 Michelle Cope National Association of Chain Drug Stores
3 Sterling Ransone, M.D. American Academy of Family Physicians
4 Anna Kesic Empower
5 Robin Plumer, M.D. Practitioner
6 Jodi Sullivan Investigations Medicare Drug Integrity Contractor
7 Kevin Duane PharmD
8 Kelly Clark, M.D. American Society of Addiction Medicine
9 Teddy Weathersbee Social Science and Public Health Researcher
10 Tichianna Armah, M.D. Yale School of Medicine;
Community Health Center, Inc.;
American Psychiatric Association
11 John Lusins, M.D. Psychiatrist
12 Jeffrey Chester, M.D. Practitioner
13 Jerome Cohan Catalyst Health Solutions
14 Tony Pratt Piedmont Access to Health Services


View Telemedicine Listening Session DAY 2, September 13, 2023:

Day 2 Transcript (PDF)

In Person Commenters:

Commenter Name Organization
1 Laura Jantos Healthcare Technology and Digital Healthcare Management Consultant
2 Felicia Bailey Family Nurse Practitioner, Avaesen Healthcare
3 Bruce Bassi, M.D. Telepsych Health
4 Alex Armitage, M.D. Baylor Scott & White Health
5 Roxanne Tyroch, M.D. Intellimedicine PA
6 Connie Guille, M.D. Medical University of South Carolina
7 Caitlin Gillooley American Hospital Association
8 Marc Berger, M.D. Practitioner
9 John Heaphy New York State Department of Health, Office of Addiction Services, Department of Health Mental Health
10 Philip Moore, M.D. Gaudenzia
11 Jesse Ehrenfeld, M.D. American Medical Association
12 Delphine Huang, M.D. California Mental Health Service Authority
13 Sarah Spencer, M.D. Ninilchik Tribal Council, Alaska Tribal Health Consortium
Virtual Commenters:

Commenter Name Organization
1 Danielle Vaeth Qbtech
2 Stephen Martin, M.D. Boulder Care
3 Ujjwal Ramtekkar, M.D. Quartet Health
4 Christa Natoli, Yael Harris CTEL, Laurel Health Advisors
5 John Wells Louisiana State University Health Sciences Center
6 Juan Hincapie-Castillo, PharmD National Pain Advocacy Center
7 James Ulager, M.D Pursuecare
8 Halley Crissman, M.D. Planned Parenthood Federation of America
9 Jessica Rigsby Ophelia Health, Inc.
10 Marcelo Fernandez-Vina The Pew Charitable Trusts
11 Dan Golden East Coast Telepsychiatry
12 Kevin Simon, M.D. Boston Children's Hospital Division Of Addiction Medicine
13 Shirley Reddoch, M.D. Practitioner


Emergency Disaster Relief
Search for Year Round Pharmaceutical Disposal Locations.
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility